Innovation and Investment Surge Reshape Blood Group Typing Landscape, Market Set to Exceed $4.8 Billion by 2032
Strategic M&As, Next-Gen Molecular Diagnostics, and Global Health Initiatives Drive Unprecedented Growth in Critical Healthcare Sector…
Strategic M&As, Next-Gen Molecular Diagnostics, and Global Health Initiatives Drive Unprecedented Growth in Critical Healthcare Sector…